Development of a nomogram model for predicting pulmonary tuberculosis activity
- PMID: 41204497
- DOI: 10.1097/MD.0000000000045582
Development of a nomogram model for predicting pulmonary tuberculosis activity
Abstract
Timely and accurate identification of active pulmonary tuberculosis (APTB) is essential for effective treatment and public health control. This study aimed to develop a predictive nomogram using routine laboratory parameters to distinguish APTB from non-active pulmonary tuberculosis. A retrospective observational study was conducted at a single tertiary hospital from January 2021 to December 2024. A total of 356 newly diagnosed PTB patients were enrolled and classified into APTB (n = 225) or non-active pulmonary tuberculosis (n = 131) groups based on clinical, radiological, and microbiological criteria. Demographic, clinical, and laboratory data were collected. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of APTB. A nomogram was constructed using 5 selected variables. Model performance was evaluated using receiver operating characteristic curves, calibration plots, and decision curve analysis. Multivariate analysis identified mean corpuscular volume, erythrocyte sedimentation rate, serum albumin, adenosine deaminase, and monocyte-to-high-density lipoprotein cholesterol ratio as independent predictors. The nomogram demonstrated strong discrimination (area under the curve = 0.913, sensitivity = 87.68%, specificity = 95.32%) and calibration (C-index = 0.915; Hosmer-Lemeshow P = .915). Decision curve analysis confirmed the model's clinical utility. An internally validated nomogram incorporating 5 accessible laboratory indicators provides a reliable tool for predicting APTB, thereby facilitating timely diagnosis and supporting clinical decision-making.
Keywords: erythrocyte sedimentation rate; monocyte-to-HDL ratio; nomogram; predictive model; pulmonary tuberculosis; serum albumin.
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Chen S, Ye J, Wang Y, Tang X, Xie W. Analysis of clinical characteristics and detection of pathogens in patients with pulmonary tuberculosis complicated with fungal infection. Minerva Med. 2023;114:754–6.
-
- Sossen B, Richards AS, Heinsohn T, et al. The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis. Lancet Respir Med. 2023;11:367–79.
-
- Ko Y, Min J, Kim HW, et al. Time delays and risk factors in the management of patients with active pulmonary tuberculosis: nationwide cohort study. Sci Rep. 2022;12:11355.
-
- Souza Filho JBOE, Sanchez M, Seixas JM, et al. Screening for active pulmonary tuberculosis: development and applicability of artificial neural network models. Tuberculosis (Edinb). 2018;111:94–101.
-
- Liu W, Xu Y, Yang L, et al. Risk factors associated with pulmonary hypertension in patients with active tuberculosis and tuberculous destroyed lung: a retrospective study. Sci Rep. 2024;14:10108.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
